Screening for Airborne Pathogen Exposure in Healthcare Workers

Abstract

Healthcare workers (HCWs) are at increased risk of occupational exposure to airborne pathogens, including Mycobacterium tuberculosis, influenza viruses, SARS-CoV-2, and others. Effective screening is essential to prevent nosocomial transmission, protect workforce health, and ensure patient safety. This review synthesizes recent evidence, mechanisms of airborne transmission, risk factors, clinical manifestations, and current diagnostic approaches, as well as management strategies and emerging technologies. Guideline-based recommendations and future directions for improving surveillance and prevention in healthcare settings are discussed.

Introduction

Occupational exposure to airborne pathogens poses a significant threat to healthcare workers globally. The dynamic healthcare environment, characterized by close patient contact and frequent aerosol-generating procedures, amplifies the risk of airborne transmission. The ongoing COVID-19 pandemic has further underscored the critical need for robust screening protocols and infection control measures. This review aims to provide clinicians, infection control specialists, and policymakers with an up-to-date synthesis of the epidemiology, pathophysiology, risk assessment, and evidence-based screening strategies for airborne pathogen exposure in healthcare workers.

Epidemiology / Disease Burden

Healthcare-associated infections (HAIs) attributable to airborne pathogens represent a substantial burden within the health sector. Tuberculosis (TB) remains a leading cause of occupational illness in HCWs, with prevalence rates among HCWs several-fold higher than the general population in high-burden countries. The emergence of novel respiratory viruses such as SARS-CoV, MERS-CoV, and SARS-CoV-2 has resulted in widespread outbreaks among hospital staff, leading to significant morbidity, mortality, and workforce shortages. Influenza and varicella-zoster virus also contribute to seasonal and sporadic outbreaks. The psychological impact, including anxiety and post-exposure stress, further compounds the disease burden among HCWs.

Pathophysiology

Airborne pathogens are transmitted primarily via droplet nuclei or aerosols generated from coughing, sneezing, talking, or medical procedures. These particles can remain suspended in the air for extended periods, facilitating transmission over distances greater than conventional droplets. Upon inhalation, pathogens can bypass mucosal defenses, leading to colonization or infection of the respiratory tract. Host susceptibility, pathogen virulence, and environmental factors—such as ventilation, humidity, and crowding—modulate the risk and severity of infection. Some pathogens, notably Mycobacterium tuberculosis, may induce latent infection, complicating diagnosis and management.

Risk Factors

Several factors increase HCWs’ susceptibility to airborne pathogen exposure. These include prolonged patient contact, especially with individuals harboring undiagnosed respiratory infections; participation in aerosol-generating procedures (e.g., intubation, bronchoscopy); suboptimal use or availability of personal protective equipment (PPE); inadequate ventilation systems; and high patient volumes. Immunocompromised HCWs or those with underlying respiratory conditions are at heightened risk of severe outcomes. Institutional factors, such as lack of infection control training or insufficient screening protocols, further exacerbate occupational exposure.

Clinical Features

Clinical manifestations in exposed HCWs vary depending on the pathogen. Tuberculosis may present with chronic cough, hemoptysis, weight loss, and night sweats, or remain asymptomatic in latent infection. Influenza and SARS-CoV-2 typically cause acute respiratory illness, with symptoms ranging from mild upper respiratory tract involvement to severe pneumonia and acute respiratory distress syndrome (ARDS). Some infections, such as measles or varicella, may present with characteristic rashes. Asymptomatic carriage or subclinical infection is particularly concerning due to the risk of silent transmission within healthcare settings.

Diagnosis

Screening strategies for airborne pathogens incorporate a combination of symptom-based assessment, exposure history, and laboratory testing. For TB, tuberculin skin testing (TST) and interferon-gamma release assays (IGRAs) are routinely employed for latent infection, while chest radiography and sputum analysis aid in detecting active disease. Molecular diagnostic methods, including PCR-based assays, are increasingly utilized for rapid detection of viral pathogens, such as SARS-CoV-2 and influenza, directly from respiratory specimens. Serological tests may be useful for retrospective exposure assessment or for pathogens with longer incubation periods. Environmental surveillance, such as air sampling and monitoring of ventilation systems, complements individual screening.

Treatment & Management

Management of exposed HCWs hinges on early identification, risk stratification, and implementation of post-exposure prophylaxis (PEP) where indicated. For TB, treatment of latent infection reduces progression to active disease. Antiviral PEP is considered for selected viruses, such as influenza and varicella, based on exposure risk and immune status. Symptomatic HCWs should be excluded from patient care until considered non-infectious. Robust contact tracing, active surveillance, and occupational health support are essential components of outbreak containment. Psychological support and counseling are vital to address mental health sequelae following high-risk exposures.

Recent Advances / Emerging Therapies

Technological advancements have enhanced the sensitivity and speed of airborne pathogen detection. Next-generation sequencing (NGS) allows for rapid identification of novel pathogens during outbreaks. Point-of-care molecular diagnostics and multiplex PCR panels facilitate timely screening in high-risk settings. Digital contact tracing, wearable biosensors, and real-time environmental monitoring are emerging as adjuncts to traditional screening. Advances in HVAC system engineering, including ultraviolet germicidal irradiation (UVGI) and HEPA filtration, provide additional layers of protection in healthcare facilities. Furthermore, development of broadly protective vaccines and monoclonal antibodies offers promise for future outbreak mitigation.

Guideline Recommendations

Major health organizations, including the CDC, WHO, and national occupational health bodies, recommend routine screening of HCWs for latent TB, especially after known exposures or in high-burden settings. Universal symptom screening, rapid molecular testing for respiratory viruses, and implementation of standard, contact, and airborne precautions are emphasized during outbreaks. Fit-testing and training in appropriate PPE use, maintaining adequate ventilation, and prompt isolation of suspected cases are foundational to prevention. Periodic review and updating of institutional protocols, based on evolving evidence and local epidemiology, are critical for sustaining effective screening programs.

Conclusion

Screening for airborne pathogen exposure among healthcare workers is a cornerstone of occupational health and patient safety. Advances in diagnostic technologies, robust infection control policies, and adherence to evidence-based guidelines are vital for minimizing the risk of nosocomial transmission. Ongoing research into novel screening tools, environmental control measures, and immunoprophylaxis will further strengthen occupational health frameworks. Ultimately, a multidisciplinary and proactive approach is essential to safeguard the health of healthcare workers and the communities they serve.